S. C. Seferina

Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases.

P. V. van Diest, P. Bult, M. de Boer, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Transferability of model-based economic evaluations: the case of trastuzumab for the adjuvant treatment of HER2-positive early breast cancer in the Netherlands.

J. Severens, V. Tjan-Heijnen, M. Joore, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.